Effects of short-term testosterone administration on variables of the metabolic syndrome, in particular aldosterone.

Unlabelled: Abstract Background: The ATPIII criteria of the metabolic syndrome (MS) comprise impaired fasting glucose (>5.6 nmol/L), waist circumference >102 cm, hypertension (>130/85 mm Hg), high triglycerides (>1.7 nmol/L) and low HDL cholesterol (≤1.

Testosterone and obesity in men under the age of 40 years.

The study assessed anthropometric and laboratory variables, in particular testosterone (T) in a group of obese men of <40 years. Of 60 men with a body mass index (BMI) of >27 kg m(-2), 34 met the criteria of the metabolic syndrome (MS). Twenty men <40 years (with a BMI <25 kg m(-2)) were studied for comparison.

Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone.

This study tested 60 men, aged <40 years, with a BMI 27-35 kg/m(2) to determine whether they had metabolic syndrome. The three definitions used to test this were from the National Cholesterol Education Program (NCEP), the World Health Organization (WHO) and the International Diabetes Federation (IDF). Further, the relationship between a positive definition and plasma testosterone (T) and calculated free T was analysed.

[Dehydroepiandrosterone and adrenarche].

The first report on increased production of 17-ketosteroids in healthy children before puberty was published by N. Talbot et al. in 1943.